As of 2025-07-14, the Intrinsic Value of Valeo Pharma Inc (VPH.TO) is (5.74) CAD. This VPH.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.05 CAD, the upside of Valeo Pharma Inc is -12,849.60%.
The range of the Intrinsic Value is (67.06) - (3.36) CAD
Based on its market price of 0.05 CAD and our intrinsic valuation, Valeo Pharma Inc (VPH.TO) is overvalued by 12,849.60%.
Note: result may not be accurate due to the invalid valuation result of DCF model.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (67.06) - (3.36) | (5.74) | -12849.6% |
| DCF (Growth 10y) | (4.72) - (102.88) | (8.41) | -18781.3% |
| Fair Value | -1.63 - -1.63 | -1.63 | -3,716.63% |
| P/E | 0.03 - 0.03 | 0.03 | -27.7% |
| EPV | (1.86) - (3.31) | (2.59) | -5846.8% |
| DDM - Stable | (3.56) - (11.53) | (7.54) | -16860.7% |
| DDM - Multi | (4.42) - (11.04) | (6.30) | -14106.5% |
| Market Cap (mil) | 4.44 |
| Beta | 0.79 |
| Outstanding shares (mil) | 98.68 |
| Enterprise Value (mil) | 67.40 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.47% |
| Cost of Debt | 11.56% |
| WACC | 8.52% |